Aberrant elevation of AEG-1 expression occurs in a series of human cancers, such as gastric cancer, breast cancer, osteosarcoma, non-small cell lung cancer, and colon cancer, compared to the matched non-neoplastic regions [5-9]. Here, MTDH is linked to breast carcinoma.